Clinical Trial Update: Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating decitabine with HAAG regimen for newly diagnosed T-ALL and related T-ALL/LBL conditions with myeloid markers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoblastic Leukemia Lymphoma
• T-cell Myeloid Mixed Phenotype Acute Leukemia
• T-lymphoblastic Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• HAAG regimen

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Induction Chemotherapy, Acute T-Lymphocytic Leukemia | Phase 3 | Status: UNKNOWN